Sanofi Continues Consumer Health Trim, Sells Kaopectate US Rights To Arcadia
Executive Summary
Sanofi sells US rights to anti-diarrhea Kaopectate brand to Arcadia Consumer Healthcare, which plans to invest in marketing and innovation behind the brand. Arcadia also markets the Nizoral dandruff shampoo and Fungi-Nail consumer health brands.
You may also be interested in...
Only US OTC Ketoconazole Dandruff Shampoo Approved For 'Professional Sample' Marketing
With Nizoral A-D sample packages approved for distribution, Arcadia has opportunity to expand sales by providing samples which dermatologists and other doctors can offer and recommend to patients.
Sanofi Looks To Future After Difficult 2019
With Consumer Healthcare sales down for Sanofi in 2019, CEO Hudson says the firm must do more to turn performance around. Key to achieving this will be the creation of a more agile standalone OTC business.
Sanofi Forms Standalone Consumer Healthcare Unit: Prelude To Spin-Off?
Sanofi Consumer Healthcare is to operate as a standalone unit in a move which is being viewed as a prelude to a potential spin-off. High profile prescription-to-OTC switches are a priority for the revamped business.